News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
January 08, 2024
Tags
Investing
stocks
Novo Nordisk A/S
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
AstraZeneca PLC
Biotech and Pharmaceuticals
Novartis AG
From
CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
Tags
Stock markets
Moderna Inc
Business News
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Companies
Business
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
Tags
Eli Lilly and Co
Business
US STEEL DRN
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Weight management
Business News
Pfizer Inc
From
CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
Tags
Companies
Breaking news
Business
From
CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
December 05, 2023
Tags
Breaking news
Companies
Business
From
CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
December 05, 2023
Tags
Breaking News: Politics
Markets
Investing
From
CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 04, 2023
Tags
Markets
stocks
Hormel Foods Corp
From
CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
December 02, 2023
Tags
Biotechnology
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Companies
US: News
Business
From
CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
Tags
Business News
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
Tags
Science
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
Tags
U/S/ Markets
Investment Strategy
Business
From
CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
Tags
Biotechnology
Novo Nordisk A/S
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Monday
November 13, 2023
Tags
Target Corp
Walt Disney Co
Macy's Inc
From
CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
November 11, 2023
Tags
Science
Pharmaceuticals
Health & Science
From
CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
Tags
U/S/ Markets
Macy's Inc
Home Depot Inc
From
CNBC.com News
Cramer's Lightning Round: Buy AutoZone
November 09, 2023
Tags
Markets
stocks
S&P 500
From
CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
Tags
Business News
Breaking News: Business
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
November 02, 2023
Tags
Health & Science
Biotech and Pharmaceuticals
US: News
From
CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
November 02, 2023
Tags
Novo Nordisk A/S
Biotechnology
Health care industry
From
CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
November 02, 2023
Tags
Pharmaceuticals
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Business News
Weight management
Biotechnology
From
CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
October 31, 2023
Tags
Coronavirus
Biotech and Pharmaceuticals
Earnings
From
CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
Tags
Technology
Breaking News: Technology
Weight management
From
CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
October 24, 2023
Tags
Market Outlook
Arm Holdings PLC
Consumer prices
From
CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
October 23, 2023
Tags
Novo Nordisk A/S
Asia Markets
Alphabet Inc
From
CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
Tags
Eli Lilly and Co
Novo Nordisk A/S
Breaking News: Investing
From
CNBC.com News
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.